Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review

European Journal of Cancer

Volumn 34, Issue 12, 1998, Pages 1836-1844

  Tramer M R ^a,b   Reynolds, D J M ^c   Stoner, N S ^c   Moore, R A ^a   McQuay, H J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b Faculty of Medicine   (Switzerland)

^c NONE

Author keywords

Granisetron; Meta analysis; Nausea; Ondansetron; Radiotherapy; Systematic review; Vomiting

Indexed keywords

DEXAMETHASONE; GRANISETRON; LORAZEPAM; METOCLOPRAMIDE; ONDANSETRON; PROCHLORPERAZINE; SEROTONIN 3 ANTAGONIST; TROPISETRON; ANTIEMETIC AGENT; SEROTONIN ANTAGONIST;

ANTIEMETIC ACTIVITY; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION SICKNESS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING; META ANALYSIS; RADIOTHERAPY;

ANTIEMETICS; GRANISETRON; HUMANS; NAUSEA; ONDANSETRON; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIALS; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; VOMITING;

EID: 0032196260     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00161-0     Document Type: Article

References (55)

1. 1. Danjoux CE, Rider WD, Fitzpatrick PJ. The acute radiation syndrome. A memorial to William Michael Court-Brown. Clin Radiol 1979, 30, 581-584.
2. 2. Chaillet MP, Cosset JM, Socie G, et al. Prospective study of the clinical symptoms of therapeutic whole body irradiation. Health Phys 1993, 64, 370-374.
3. 3. Miralbell R, Coucke P, Behrouz F, et al. Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide. Eur J Cancer 1995, 31A, 1461-1464.
4. 4. Westbrook C, Glaholm J, Barret A. Vomiting associated with whole body irradiation. Clin Radiol 1987, 38, 263-266.
5. 5. Andrews PLR, Rapeport WG, Sanger GJ. Neuropharmacology of emesis induced by anti-cancer therapy. TIPS 1988, 9, 334-341.
6. 3 receptor antagonists and radiation-induced emesis: preclinical data. In Reynolds DJM, Andrews PLR, Davis CJ, eds. Serotonin and the scientific basis of anti-emetic therapy. Oxford, Oxford Clinical Communications, 1995, 127-133.
7. 3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer 1997, 33, 66-74.
8. 8. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Efficacy, dose-response, and safety of ondansetron in prevention of post-operative nausea and vomiting: a quantitative systematic review of randomised placebo-controlled trials. Anesthesiology 1997, 87, 1277-1289.
9. 9. Tramèr MR, Moore RA, Reynolds DJM, McQuay HJ. A quantitative systematic review of ondansetron in treatment of established postoperative nausea and vomiting. Br Med J 1997, 314, 1088-1092.
10. 10. Morris JA, Gardner MJ. Calculating confidence intervals for relative risk, odds ratios, and standardised ratios and rates. In Gardner MJ, Altman DG, eds. Statistics with confidence - confidence intervals and statistical guidelines. London, British Medical Journal, 1995, 50-63.
11. 11. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. New Engl J Med 1988, 318, 1728-1733.
12. 12. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995, 310, 452-445.
13. 13. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Ann Intern Med 1997, 126, 712-720.
14. 14. Bosi A, Guidi S, Messori A, et al. Ondansetron versus chlorpromazine for preventing emesis in bone marrow transplant recipients: a double-blind randomized study. J Chemother 1993, 5, 191-196.
15. 15. Collis CH, Priestman, TJ, Priestman, S, et al. The final assessment of a randomized double-blind comparative study of ondansetron versus metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol 1991, 3, 241-243.
16. 16. Franzén L, Nyman J, Hagberg H, et al. A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. Ann Oncol 1996, 7, 587-592.
17. 17. Prentice HG, Cunningham S, Gandhi L, Cunningham J, Collis C, Hamon MD. Granisetron in the prevention of irradiation-induced emesis. Bone Marrow Transplant 1995, 15, 445-448.
18. 18. Hayashida S, Hirasawa T, Uchiyama K, Mitsui H, Nasu T, Shinohara Y. The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy - a study of forty patients with bladder cancer. Gan To Kagaku Ryoho 1995, 22, 639-646.
19. 19. Labar B, Mrsicc M, Nemet D, et al. Ondansetron for prophylaxis of nausea and vomiting after bone marrow transplantation. Libri Oncol 1995, 24, 131-135.
20. 20. Priestman TJ. Clinical studies with ondansetron in the control of radiation-induced emesis. Eur J Cancer 1989, 25(Suppl. 1), S29-S33.
21. 21. Priestman TJ, Roberts JT, Lucraft H, et al. Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation. Clin Oncol 1990, 2, 71-75.
22. 22. Priestman TJ, Roberts JT, Upadhyaya BK. A prospective randomized double-blind trial comparing ondansetron versus prochlorperazine for the prevention of nausea and vomiting in patients undergoing fractionated radiotherapy. Clin Oncol 1993, 5, 358-363.
23. 23. Roberts JT, Priestman TJ. A review of ondansetron in the management of radiotherapy-induced emesis. Oncology 1993, 50, 173-179.
24. 24. Spitzer TR, Bryson JC, Cirenza E, et al. Randomized double-blind, placebo-controlled evaluation of oral ondansetron in the prevention of nausea and vomiting associated with fractionated total-body irradiation. J Clin Oncol 1994, 12, 2432-2438.
25. 25. Tiley C, Powles R, Catalano J, et al. Results of a double blind placebo controlled study of ondansetron as an antiemetic during total body irradiation in patients undergoing bone marrow transplantation. Leuk Lymphoma 1992, 7, 317-321.
26. 26. Bodis S, Alexander E, Kooy H, Loeffler JS. The prevention of radiosurgery-induced nausea and vomiting by ondansetron: evidence of a direct effect on the central nervous system chemoreceptor trigger zone. Surg Neurol 1994, 42, 249-252.
27. 27. Huang X, Guo N, Fan Y. Ondansetron in the prophylaxis of acute emesis induced by supra-high single dose total body irradiation (TBI). Chung Hua Chung Liu Tsa Chih 1995, 17, 64-66.
28. 28. Scarantino CW, Ornitz RD, Hoffman LG, Anderson Jr RF. Radiation-induced emesis: effects of ondansetron. Semin Oncol 1992, 19, 38-43.
29. 29. Scarantino CW, Ornitz RD, Hoffman LG, Anderson Jr RF. On the mechanism of radiation-induced emesis: the role of serotonin. Int J Radiat Oncol 1994, 30, 825-830.
30. 30. Barbieri E, Perini F, Delduca M, Pica A, Chiaulon G, Babini L. Brief report on the use of tropisetron (ICS 205-930) in radiotherapy-induced emesis in patients resistant to metoclopramide. Eur J Clin Res 1994, 5, 135-140.
31. 31. Belkacemi Y, Ozsahin M, Pene F, et al. Total body irradiation prior to bone marrow transplantation: efficacy and safety of granisetron in the prophylaxis and control of radiation-induced emesis. Int J Radiat Oncol 1996, 36, 77-82.
32. 32. Feuvret L, Jammet P, Campana F, Cosset JM, Fourquet A. Intérêt du granisetron dans la prévention des troubles digestifs lors des irradiations corporelles totales. Bull Cancer Radiother 1994, 81, 41-44.
33. 33. Henriksson R, Lomberg H, Israelsson G, Zackrisson B, Franzén L. The effect of ondansetron on radiation-induced emesis and diarrhoea. Acta Oncol 1992, 31, 767-769.
34. 3 antagonist. Bone Marrow Transplant 1991, 7, 431-433.
35. 3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation. Bone Marrow Transplant 1991, 7, 439-441.
36. 36. Jürgens H, McQuade B. Ondansetron as prophylaxis for chemotherapy and radiotherapy-induced emesis in children. Oncology 1992, 49, 279-285.
37. 37. Lippens RJJ, Breeders GCJM. Ondansetron in radiation therapy of brain tumor in children. Pediatr Hemat Oncol 1996, 13, 247-252.
38. 38. Logue JP, Magee B, Hunter RD, Murdoch RD. The antiemetic effect of granisetron in lower hemibody radiotherapy. Clin Oncol 1991, 3, 247-249.
39. 39. Or R, Drakos P, Nagler A, Naparstek E, Kapelushnik J, Cass Y. The anti-emetic efficacy and tolerability of tropisetron in patients conditioned with high-dose chemotherapy (with and without total body irradiation) prior to bone marrow transplantation. Support Care Cancer 1994, 2, 245-248.
40. 40. Schwella N, Konig V, Schwerdtfeger R, et al. Ondansetron for efficient emesis control during total body irradiation. Bone Marrow Transplant 1994, 13, 169-171.
41. 3 receptor antagonist, in the prevention of radiation-induced emesis. Radiother Oncol 1992, 23, 131-132.
42. 3-receptor antagonist, in the prevention of radiation-induced nausea, vomiting and diarrhoea. Drugs 1992, 43(Suppl 3), 33-39.
43. 43. Sullivan MJ, Abbott GD, Robinson BA. Ondansetron antiemetic therapy for chemotherapy and radiotherapy induced vomiting in children. N Z Med J 1992, 105, 369-371.
44. 44. Rosenthal SA, Marquez CM, Hourigan HP, Ryu JK. Ondansetron for patients given abdominal radiotherapy (letter). Lancet 1992, 339, 490.
45. 45. Roberts JT. Ondansetron in the control of refractory emesis following radiotherapy (letter). Clin Oncol 1992, 4, 67-68.
46. 46. Foot AB, Hayes C. Audit of guidelines for effective control of chemotherapy and radiotherapy induced emesis. Arch Dis Child 1994, 71, 475-480.
47. 3 receptor antagonist, in the prevention of irradiation-induced nausea, vomiting and diarrhoea. Eur J Gynaecol Oncol 1992, 13, 382-389.
48. 48. Schulz KF, Chalmers I, Hayes RJ, Altman DC. Empirical evidence of bias. JAMA 1995, 273, 408-412.
49. 49. Carroll D, Tramèr MR, McQuay H, Nye B, Moore A. Randomization is important in studies with pain outcomes: systematic review of transcutaneous electrical nerve stimulation in acute postoperative pain. Br J Anaesth 1996, 77, 798-803.
50. 50. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. Impact of covert duplicate publication on meta-analysis: a case study. Br Med J 1997, 315, 635-640.
51. 51. Tramèr MR, Reynolds DJM, Moore RA, McQuay HJ. When placebo controlled trials are essential and equivalence trials are inadequate. Br Med J 1998, 317, 875-880.
52. 52. Coates A, Abraham S, Sowerbutts T, Frewin C, Fox RM, Tattersall MHN. On the receiving end - patient perception of the side-effects of cancer chemotherapy. Eur J Clin Oncol 1983, 19, 203-208.
53. 53. Dicato MA, Freeman AJ. Experience with ondansetron in chemotherapy-and radiotherapy-induced emesis. Eur J Anaesthesiol 1992, 9 (Suppl 6), 19-24.
54. 54. Lévy E, Paillarse JM, Votan B. Efficacité de l'ondansetron dans les nausées et vomissements radio-induits: revue de la litérature. Bull Cancer Radiother 1994, 81, 179-185.
55. 55. Yarker YE, McTavish D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy. Drugs 1994, 48, 761-793.